Good morning—Friday, September 19, 2025.
Market Pulse Metals and biotech led a rebound yesterday after FedEx powered through estimates on its latest earnings report and biotech bulls rallied behind fresh FDA approvals.
Key Movers FedEx stunned Wall Street with a 5% after-hours pop on better-than-expected results, Incyte’s Opzelura snagged another FDA green light, and chatter around a Tesla short squeeze around $440 is heating up again.
Macro & Politics Presidential contender Gareth Sheridan’s partner is under fire for Russian ties, while Hollywood unions and free-speech hawks are clashing over Jimmy Kimmel’s suspension—expect headlines to stay charged.
What’s Next Earnings season ramps up next week and whispers of a dovish Fed tilt could spark rallies in rate-sensitive stocks.
Unfiltered Market Commentary
What everyone’s missing is that the political heat isn’t just noise—it’s a catalyst. Article “What are presidential hopeful Gareth Sheridan’s business partner’s links with Russia?” from The Irish Times shows ethics probes could sap risk appetite if investors start pricing in sanctions risk. That undercurrent might steer traders out of momentum names faster than they jump in on short-squeeze chatter.
Look at it this way: FedEx’s blowout results and Incyte’s FDA victory are fueling bullish momentum, but they’re playing off the same narrative—big-cap winners rallying on execution. Pair that with Tesla’s potential squeeze from Biztoc.com’s “Is Tesla Stock About to Short Squeeze? TSLA Traders Eye $440 as Key Level,” and you’ve got froth on top of froth. It’s one hell of a risky cocktail.
Your move: don’t just chase headlines. Tilt into the setups backed by solid catalysts—lock in gains on winners like FedEx, scout biotech names riding approvals, and keep a hedge for the political curveballs that could send broad markets swinging without warning.
📈 Breaking Financial News
Biztoc.com
has strung together seven straight green days and added roughly $79 a share over that span. In early trading the stock hovered around $432.50, up about 1.6% before the bell while the broader market also pointed higher. Momentum traders love this kind of tape,…
Thefly.com
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Thefly.com
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Yahoo Entertainment
In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Glaukos Corporation stands seventh among them. Glaukos…
The Irish Times
Moldovan investors own bulk of Sheridan’s Nutriband business, US filings show
“I said ‘SELL' before this stock dropped 90%. Today, I'm shouting ‘BUY NOW' before it's too late.”
In 2000, Eric Fry told Barron's magazine that investors should sell a very popular dot-com stock just before it plunged 90%. Today, Eric is saying the exact opposite about it – “BUY NOW!” This same company is now the lifeblood of AI data centers – yet it's completely undervalued. He says anyone who owns Nvidia stock would be well-served to sell those shares and buy this under-the-radar play instead. Get Eric's full take on the situation right here…
🔍 Market Analysis & Insights
TheWrap
“Corporations are selling out working families and our American freedoms to amass even greater wealth,” the union says
The post Hollywood Teamsters Condemn Kimmel Shutdown as ‘Greed-Fueled Consolidation of Corporate Power’ appeared first on TheWrap.
Newser
Novo Nordisk's pill version of Wegovy could be just as effective as the injectable shot, according to new clinical trial data released by the company. In the study, overweight or obese adults took the daily oral medication as prescribed lost an average of 16.…
MSNBC
After a threat from FCC Chairman Brendan Carr, ABC pulled “Jimmy Kimmel Live!” off the air. And Trump's censorship regime is just getting started.
Vulture
By pulling Jimmy Kimmel off the air, Bob Iger might have tarnished his legacy in Hollywood. Joe Adalian digs into what Disney is thinking — and what happens next.
GlobeNewswire
– On track for first FDA Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – Los…
$20 = Ounce of Gold?
I've discovered a way to get exposure to MORE than an ounce of gold… for under $20. It's not bullion. It's not ETFs. And it's certainly not crypto. Rather, it's a unique gold play that has outperformed physical gold by 10X over 25 years…
💰 Investment Opportunities
Cosmopolitan.com
This trending K-Beauty treatment uses salmon DNA (PDRN) to boost collagen and revive dull skin. Discover how it works, the cost, the side effects, and more.
GlobeNewswire
The overactive bladder treatment market is experiencing steady growth driven by the increasing prevalence of OAB, especially among the aging population. Rising awareness about urinary disorders and the availability of new pharmacological therapies, including …
BusinessLine
WNS Global anticipates growth in headcount and revenue post-merger with Capgemini, focusing on untapped market potential.
GlobeNewswire
Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operations Donnelly brings more than 25 years of biopharmaceutical expertise in CMC and regulatory operations
Forget Google, Forget ChatGPT: Elon's xAI Is Here
Elon's not playing around. He's built the world's most powerful supercomputer to create a superhuman AI. Here’s how you can claim your stake in his private company, xAI.